These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24072649)

  • 1. Silencing synuclein at the synapse with PLK2.
    Looyenga BD; Brundin P
    Proc Natl Acad Sci U S A; 2013 Oct; 110(41):16293-4. PubMed ID: 24072649
    [No Abstract]   [Full Text] [Related]  

  • 2. Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo.
    Oueslati A; Schneider BL; Aebischer P; Lashuel HA
    Proc Natl Acad Sci U S A; 2013 Oct; 110(41):E3945-54. PubMed ID: 23983262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
    Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
    Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
    Hong CT; Chen KY; Wang W; Chiu JY; Wu D; Chao TY; Hu CJ; Chau KD; Bamodu OA
    Cells; 2020 Mar; 9(3):. PubMed ID: 32192190
    [No Abstract]   [Full Text] [Related]  

  • 5. Dissecting the Molecular Pathway Involved in PLK2 Kinase-mediated α-Synuclein-selective Autophagic Degradation.
    Dahmene M; Bérard M; Oueslati A
    J Biol Chem; 2017 Mar; 292(9):3919-3928. PubMed ID: 28154193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications.
    Qing H; Wong W; McGeer EG; McGeer PL
    Biochem Biophys Res Commun; 2009 Sep; 387(1):149-52. PubMed ID: 19576176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein disrupts stress signaling by inhibiting polo-like kinase Cdc5/Plk2.
    Wang S; Xu B; Liou LC; Ren Q; Huang S; Luo Y; Zhang Z; Witt SN
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16119-24. PubMed ID: 22988096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system.
    Inglis KJ; Chereau D; Brigham EF; Chiou SS; Schöbel S; Frigon NL; Yu M; Caccavello RJ; Nelson S; Motter R; Wright S; Chian D; Santiago P; Soriano F; Ramos C; Powell K; Goldstein JM; Babcock M; Yednock T; Bard F; Basi GS; Sham H; Chilcote TJ; McConlogue L; Griswold-Prenner I; Anderson JP
    J Biol Chem; 2009 Jan; 284(5):2598-2602. PubMed ID: 19004816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLK2 modulates α-synuclein aggregation in yeast and mammalian cells.
    Basso E; Antas P; Marijanovic Z; Gonçalves S; Tenreiro S; Outeiro TF
    Mol Neurobiol; 2013 Dec; 48(3):854-62. PubMed ID: 23677647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization.
    Samuel F; Flavin WP; Iqbal S; Pacelli C; Sri Renganathan SD; Trudeau LE; Campbell EM; Fraser PE; Tandon A
    J Biol Chem; 2016 Feb; 291(9):4374-85. PubMed ID: 26719332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.
    Lin X; Parisiadou L; Gu XL; Wang L; Shim H; Sun L; Xie C; Long CX; Yang WJ; Ding J; Chen ZZ; Gallant PE; Tao-Cheng JH; Rudow G; Troncoso JC; Liu Z; Li Z; Cai H
    Neuron; 2009 Dec; 64(6):807-27. PubMed ID: 20064389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of polo-like kinase 2 loaded nanoparticles-A novel strategy for (serine-129) phosphorylation of alpha-synuclein.
    Rodríguez-Nogales C; Garbayo E; Martínez-Valbuena I; Sebastián V; Luquin MR; Blanco-Prieto MJ
    Int J Pharm; 2016 Nov; 514(1):142-149. PubMed ID: 27863657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA OIP5-AS1 reduces α-synuclein aggregation and toxicity by targeting miR-126 to activate PLK2 in human neuroblastoma SH-SY5Y cells.
    Song Z; Xie B
    Neurosci Lett; 2021 Jan; 740():135482. PubMed ID: 33161106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration.
    Daher JP; Abdelmotilib HA; Hu X; Volpicelli-Daley LA; Moehle MS; Fraser KB; Needle E; Chen Y; Steyn SJ; Galatsis P; Hirst WD; West AB
    J Biol Chem; 2015 Aug; 290(32):19433-44. PubMed ID: 26078453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lrrk2 and alpha-synuclein are co-regulated in rodent striatum.
    Westerlund M; Ran C; Borgkvist A; Sterky FH; Lindqvist E; Lundströmer K; Pernold K; Brené S; Kallunki P; Fisone G; Olson L; Galter D
    Mol Cell Neurosci; 2008 Dec; 39(4):586-91. PubMed ID: 18790059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superiority of PLK-2 as α-synuclein phosphorylating agent relies on unique specificity determinants.
    Salvi M; Trashi E; Marin O; Negro A; Sarno S; Pinna LA
    Biochem Biophys Res Commun; 2012 Feb; 418(1):156-60. PubMed ID: 22248692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAc modification inhibits the calpain-mediated cleavage of α-synuclein.
    Levine PM; De Leon CA; Galesic A; Balana A; Marotta NP; Lewis YE; Pratt MR
    Bioorg Med Chem; 2017 Sep; 25(18):4977-4982. PubMed ID: 28487126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron-induced oxidative stress contributes to α-synuclein phosphorylation and up-regulation via polo-like kinase 2 and casein kinase 2.
    Wang R; Wang Y; Qu L; Chen B; Jiang H; Song N; Xie J
    Neurochem Int; 2019 May; 125():127-135. PubMed ID: 30797969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study.
    Dumitriu A; Pacheco CD; Wilk JB; Strathearn KE; Latourelle JC; Goldwurm S; Pezzoli G; Rochet JC; Lindquist S; Myers RH
    Hum Mol Genet; 2011 Apr; 20(8):1478-87. PubMed ID: 21258085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.
    Covy JP; Giasson BI
    Neurotoxicology; 2011 Oct; 32(5):622-9. PubMed ID: 21238487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.